TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking
SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), represents investors who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025.
Hagens Berman is investigating the alleged claims and urges investors who purchased TransMedics shares and suffered substantial losses to submit your losses now.
Lead Plaintiff Deadline: Apr. 15, 2025
Visit:
844-916-0895
The TransMedics Group (TMDX) Class Action
The complaint alleges that TransMedics made false and misleading statements, while failing to disclose crucial information. Specifically, the suit contends that TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to boost business and revenue. Furthermore, it alleges that the company engaged in unsafe practices, concealed safety problems, and generally lacked adequate safety oversight, exposing TransMedics to heightened regulatory risk.
The lawsuit details two events that allegedly disclosed defendants' misconduct to the market that adversely impacted the company's stock price. On February 21, 2024, Representative Paul Gosar issued a letter accusing TransMedics of misappropriating corporate resources. The allegations were subsequently reported by The Daily Caller on February 22, 2024, causing a drop in TransMedics' stock price, according to the complaint.
More recently, on January 10, 2025, activist short seller Scorpion Capital released a report leveling accusations against TransMedics, including overbilling hospitals, coercing customers into using specific services, and providing patients with organs rejected by reputable physicians via doctors allegedly paid by TransMedics.
This report further depressed the company's stock price, the lawsuit claims.
Prominent investor rights firm Hagens Berman Sobol Shapiro LLP is probing whether TransMedics misled investors regarding its sales practices.
'We are looking into claims that TransMedics engaged in improper billing practices and concealed safety issues. These allegations, if true, could have significant implications for both patients and investors,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in TransMedics and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the TransMedics case and our investigation, read more »
Whistleblowers: Persons with non-public information regarding TransMedics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
Contact:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Apple Poised to Monetize AI at WWDC 2025
Apple (NASDAQ:AAPL) looks ready to kick off its AI monetization era with system-wide updates at WWDC 2025, Wedbush's Daniel Ives says, setting the stage for paid AI features across the Apple ecosystem. The keynote at 1 p.m. ET today at Apple Park will unveil '26 upgrades for macOS, iOS and iPadOS powered by Apple Intelligence, countering Street skepticism about a slow AI rollout. In his Monday note, Ives argued that WWDC marks the start of Apple's AI cash flow, not a mere feature demo, as the company layers new AI-driven capabilities into core OS updates. He expects details on Siri's deeper integration with Google's Gemini and OpenAI's ChatGPT, demonstrating how Apple will embed AI across native apps to drive user engagementand, ultimately, device upgrades when iPhone 17 ships next year. With over 100 million iPhones in China due for an upgrade, Ives also eyes an announcement on Apple's partnership with Alibaba (NYSE:BABA) to deploy AI services locally, a move he calls critical for unlocking growth in the world's largest smartphone market. Wedbush reiterates its Outperform rating and raises its 12-month price target to $270, noting that Apple's edge isn't in building the most advanced large language model but in toll-collecting'' on its vast hardware base. Apple's unmatched ecosystem ensures that any third-party AI app must run through Cupertino, highlighting how AI unlocks new services revenue without upending its product strategy. Why It Matters: WWDC's AI announcements could shift Wall Street sentiment, validating Apple's long-term AI strategy and fueling expectations for recurring software revenue beyond hardware sales. Investors will watch for concrete details on AI feature pricing, Siri-Gemini integrations and the Alibaba tie-up during today's keynote and in the follow-up developer sessions. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
33 minutes ago
- Business Wire
KBRA Assigns Preliminary Ratings to Pagaya AI Debt Grantor Trust 2025-4 and Pagaya AI Debt Trust 2025-4
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 12 classes of notes issued by Pagaya AI Debt Grantor Trust 2025-4 and Pagaya AI Debt Trust 2025-4 (collectively 'PAID 2025-4'), an unsecured consumer loan ABS transaction. PAID 2025-4 has initial hard credit enhancement levels of 65.29% for the Class A-1 Notes to 3.67% for the Class F Notes. Credit enhancement is comprised of overcollateralization, subordination (except for the Class F Notes), a cash reserve account funded at closing, and excess spread. PAID 2025-4 will issue 13 classes of notes totaling $490.0 million with KBRA rating the Class A-1 through Class F Notes, Class A, Class AB, Class ABC, Class ABCD, and Class EF Notes. KBRA will not be providing ratings on the Certificates or the FR Securities. PAID 2025-4 is a fully prefunded transaction where there will be no collateral funded at closing. Pagaya Structured Products LLC, the sponsor and administrator, is a fully owned subsidiary of Pagaya US Holding Company LLC (formerly known as Pagaya Investments US LLC), which is 100% owned by Pagaya Technologies Ltd. ('Pagaya Technologies'), an Israeli corporation listed on the NASDAQ (PGY). Pagaya Technologies is a financial technology company in the lending marketplace that uses AI-driven credit and analysis technology. This transaction is the 45th publicly rated securitization sponsored by Pagaya Structured Products LLC (collectively with its affiliates, 'Pagaya' or the 'Company'). KBRA applied its Consumer Loan ABS Global Rating Methodology, as well as its Global Structured Finance Counterparty Methodology and ESG Global Rating Methodology as part of its analysis of the transaction's proposed capital structure and Pagaya's historical static pool data. KBRA considered its operational reviews of Pagaya and each of the Platform Sellers, as well as periodic update calls with the Company and Platform Sellers. KBRA has recently conducted surveillance on each platform's KBRA-rated securitizations. Operative agreements and legal opinions will be reviewed prior to closing. To access ratings and relevant documents, click here. Click here to view the report. Methodologies Disclosures Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above. A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at About KBRA Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan's Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S. Doc ID: 1009832
Yahoo
34 minutes ago
- Yahoo
Why EchoStar Stock Is Falling Today
EchoStar has been under regulatory pressure over its use of the spectrum earmarked for a new nationwide cellular carrier. The company reportedly could consider a bankruptcy filing to help shield its spectrum licenses from the threat of revocation. 10 stocks we like better than EchoStar › Telecom and satellite company EchoStar (NASDAQ: SATS) is reportedly considering a bankruptcy filing to protect its spectrum licenses. Investors are not taking the threat lightly, sending EchoStar shares down as much as 15% at the open and down 8% as of 11 a.m. Eastern. EchoStar is a satellite television and communications company currently focused on growing a nationwide cellular business. The company owns Boost Mobile, the nation's fourth-largest wireless carrier, and is building out the network using its spectrum holdings. But regulators appear to be growing impatient with the company's progress. Reports surfaced last month that the Federal Communications Commission has opened an investigation into EchoStar's compliance with federal requirements to build out a nationwide 5G network according to milestones set in 2019. EchoStar responded with evidence that it is indeed building out the network as required, but the spectrum resources are valuable and coveted by several companies. Included in that list is SpaceX, whose chairman, Elon Musk, has complained about EchoStar's progress and demanded the spectrum be opened to other users, including SpaceX's Starlink. Late Friday, The Wall Street Journal reported EchoStar is considering a Chapter 11 bankruptcy filing as a way to shield its spectrum licenses from the threat of revocation. In theory, a filing would leave decisions about the spectrum up to a judge, not regulators. Given EchoStar's structure, it is not entirely out of the question that shareholders would get something out of a bankruptcy. But it is a very high-risk bet. In bankruptcy, equity holders have the least protection, and shares are often zeroed out. EchoStar declined to comment on the bankruptcy rumors, and a filing is far from certain. Political winds change direction quickly, and it is possible recent events in Washington could cause the FCC not to prioritize the EchoStar spectrum. If the company does file, debt holders are likely to capture a lot of the value of the reorganized company. There's a lot of risk to EchoStar right now, but also a lot of potential value if the company is allowed to continue on its path toward building Boost Mobile. Investors considering buying in should be prepared for further turbulence and limit EchoStar to a small part of a well-diversified portfolio. Before you buy stock in EchoStar, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and EchoStar wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why EchoStar Stock Is Falling Today was originally published by The Motley Fool
